Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Capital Leases (2019 - 2023)

Beam Therapeutics (BEAM) has disclosed Capital Leases for 5 consecutive years, with $304000.0 as the latest value for Q3 2023.

  • Quarterly Capital Leases fell 78.1% to $304000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $304000.0 through Sep 2023, down 78.1% year-over-year, with the annual reading at $1.2 million for FY2022, 61.62% down from the prior year.
  • Capital Leases for Q3 2023 was $304000.0 at Beam Therapeutics, down from $875000.0 in the prior quarter.
  • The five-year high for Capital Leases was $5.3 million in Q1 2020, with the low at $304000.0 in Q3 2023.
  • Average Capital Leases over 5 years is $3.0 million, with a median of $3.3 million recorded in 2021.
  • The sharpest move saw Capital Leases rose 20.02% in 2020, then tumbled 78.1% in 2023.
  • Over 5 years, Capital Leases stood at $4.4 million in 2019, then rose by 20.02% to $5.3 million in 2020, then plummeted by 43.2% to $3.0 million in 2021, then plummeted by 61.62% to $1.2 million in 2022, then crashed by 73.66% to $304000.0 in 2023.
  • According to Business Quant data, Capital Leases over the past three periods came in at $304000.0, $875000.0, and $983000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.